Obstructive Sleep Apnea and Diabetes: A State of the Art Review

Chest

Volumn 152, Issue 5, 2017, Pages 1070-1086

  Reutrakul, Sirimon ^a,b   Mokhlesi, Babak ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF ILLINOIS   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

central sleep apnea; diabetic complications; gestational diabetes; OSA; sleep apnea; type 1 diabetes; type 2 diabetes; weight loss

Indexed keywords

DISEASE ASSOCIATION; DISEASE SEVERITY; DISORDERS OF CARBOHYDRATE METABOLISM; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REM SLEEP; RESPIRATORY TRACT DISEASE ASSESSMENT; REVIEW; RISK FACTOR; SLEEP DISORDERED BREATHING; WEIGHT REDUCTION; COMORBIDITY; GLOBAL HEALTH; PREVALENCE; PREVENTIVE MEDICINE; PROCEDURES; TRENDS;

COMORBIDITY; DIABETES MELLITUS, TYPE 2; GLOBAL HEALTH; HUMANS; PREVALENCE; PREVENTIVE MEDICINE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 85033557329     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2017.05.009     Document Type: Review

References (122)

1. Heinzer, R., Vat, S., Marques-Vidal, P., et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med 3:4 (2015), 310–318.
2. Duran, J., Esnaola, S., Rubio, R., et al. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 163:3 Pt 1 (2001), 685–689.
3. Bixler, E.O., Vgontzas, A.N., Ten, H.T., et al. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 157:1 (1998), 144–148.
4. Young, T., Palta, M., Dempsey, J., et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:17 (1993), 1230–1235.
5. Bixler, E.O., Vgontzas, A.N., Lin, H.M., et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 163:3 Pt 1 (2001), 608–613.
6. Peppard, P.E., Young, T., Barnet, J.H., et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177:9 (2013), 1006–1014.
7. Centers for Disease Control and Prevention. Diabetes 2014 report card. https://www.cdc.gov/diabetes/library/reports/reportcard.html. Accessed June 16, 2017.
8. Knowler, W.C., Barrett-Connor, E., Fowler, S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:6 (2002), 393–403.
9. Punjabi, N.M., Sorkin, J.D., Katzel, L.I., et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:5 (2002), 677–682.
10. Punjabi, N.M., Beamer, B.A., Alterations in glucose disposal in sleep-disordered breathing. Am J Respir Crit Care Med 179:3 (2009), 235–240.
11. Iftikhar, I.H., Hoyos, C.M., Phillips, C.L., et al. Meta-analyses of the association of sleep apnea with insulin resistance, and the effects of CPAP on HOMA-IR, adiponectin, and visceral adipose fat. J Clin Sleep Med 11:4 (2015), 475–485.
12. Ip, M.S., Lam, B., Ng, M.M., et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:5 (2002), 670–676.
13. Spiegel, K., Leproult, R., Van Cauter, E., Impact of sleep debt on metabolic and endocrine function. Lancet 354:9188 (1999), 1435–1439.
14. Nedeltcheva, A.V., Kessler, L., Imperial, J., et al. Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance. J Clin Endocrinol Metab 94:9 (2009), 3242–3250.
15. Buxton, O.M., Pavlova, M., Reid, E.W., et al. Sleep restriction for 1 week reduces insulin sensitivity in healthy men. Diabetes 59:9 (2010), 2126–2133.
16. Broussard, J.L., Ehrmann, D.A., Van Cauter, E., et al. Impaired insulin signaling in human adipocytes after experimental sleep restriction: a randomized, crossover study. Ann Intern Med 157:8 (2012), 549–557.
17. Donga, E., van, D.M., van Dijk, J.G., et al. A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab 95:6 (2010), 2963–2968.
18. Cedernaes, J., Lampola, L., Axelsson, E.K., et al. A single night of partial sleep loss impairs fasting insulin sensitivity but does not affect cephalic phase insulin release in young men. J Sleep Res 25:1 (2016), 5–10.
19. Stamatakis, K.A., Punjabi, N.M., Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest 137:1 (2010), 95–101.
20. Tasali, E., Leproult, R., Ehrmann, D.A., et al. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci U S A 105:3 (2008), 1044–1049.
21. Herzog, N., Jauch-Chara, K., Hyzy, F., et al. Selective slow wave sleep but not rapid eye movement sleep suppression impairs morning glucose tolerance in healthy men. Psychoneuroendocrinology 38:10 (2013), 2075–2082.
22. Louis, M., Punjabi, N.M., Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol 106:5 (2009), 1538–1544.
23. Reutrakul, S., Van Cauter, E., Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes. Ann N Y Acad Sci 1311 (2014), 151–173.
24. Newhouse, L.P., Joyner, M.J., Curry, T.B., et al. Three hours of intermittent hypoxia increases circulating glucose levels in healthy adults. Physiol Rep, 5(1), 2017.
25. Oltmanns, K.M., Gehring, H., Rudolf, S., et al. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 169:11 (2004), 1231–1237.
26. Somers, V.K., Dyken, M.E., Mark, A.L., et al. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 328:5 (1993), 303–307.
27. Somers, V.K., Dyken, M.E., Clary, M.P., et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:4 (1995), 1897–1904.
28. Narkiewicz, K., Kato, M., Phillips, B.G., et al. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100:23 (1999), 2332–2335.
29. Bloom, S.R., Edwards, A.V., Hardy, R.N., The role of the autonomic nervous system in the control of glucagon, insulin and pancreatic polypeptide release from the pancreas. J Physiol 280 (1978), 9–23.
30. Lembo, G., Capaldo, B., Rendina, V., et al. Acute noradrenergic activation induces insulin resistance in human skeletal muscle. Am J Physiol 266:2 Pt 1 (1994), E242–E247.
31. Nonogaki, K., New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 43:5 (2000), 533–549.
32. Ahren, B., Holst, J.J., The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia. Diabetes 50:5 (2001), 1030–1038.
33. Balks, H.J., Holst, J.J., von zur, M.A., et al. Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: cholinergic control of GLP-1 secretion via muscarinic receptors. J Clin Endocrinol Metab 82:3 (1997), 786–790.
34. Hansen, L., Lampert, S., Mineo, H., et al. Neural regulation of glucagon-like peptide-1 secretion in pigs. Am J Physiol Endocrinol Metab 287:5 (2004), E939–E947.
35. Pamidi, S., Wroblewski, K., Stepien, M., et al. Eight hours of nightly continuous positive airway pressure treatment of obstructive sleep apnea improves glucose metabolism in patients with prediabetes. A randomized controlled trial. Am J Respir Crit Care Med 192:1 (2015), 96–105.
36. Ziegler, M.G., Mills, P.J., Loredo, J.S., et al. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest 120:3 (2001), 887–893.
37. Kohler, M., Pepperell, J.C., Casadei, B., et al. CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J 32:6 (2008), 1488–1496.
38. Myhill, P.C., Davis, W.A., Peters, K.E., et al. Effect of continuous positive airway pressure therapy on cardiovascular risk factors in patients with type 2 diabetes and obstructive sleep apnea. J Clin Endocrinol Metab 97:11 (2012), 4212–4218.
39. Mokhlesi, B., Grimaldi, D., Beccuti, G., et al. Effect of one week of CPAP treatment of obstructive sleep apnoea on 24-hour profiles of glucose, insulin and counter-regulatory hormones in type 2 diabetes. Diabetes Obes Metab 19:3 (2017), 452–456.
40. Yokoe, T., Alonso, L.C., Romano, L.C., et al. Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice. J Physiol 586:3 (2008), 899–911.
41. Xu, J., Long, Y.S., Gozal, D., et al. Beta-cell death and proliferation after intermittent hypoxia: role of oxidative stress. Free Radic Biol Med 46:6 (2009), 783–790.
42. Wang, N., Khan, S.A., Prabhakar, N.R., et al. Impairment of pancreatic beta-cell function by chronic intermittent hypoxia. Exp Physiol 98:9 (2013), 1376–1385.
43. Polak, J., Shimoda, L.A., Drager, L.F., et al. Intermittent hypoxia impairs glucose homeostasis in C57BL6/J mice: partial improvement with cessation of the exposure. Sleep 36:10 (2013), 1483–1490.
44. Grimaldi, D., Beccuti, G., Touma, C., et al. Association of obstructive sleep apnea in REM sleep with reduced glycemic control in type 2 diabetes: therapeutic implications. Diabetes Care 37:2 (2014), 355–363.
45. Chami, H.A., Gottlieb, D.J., Redline, S., et al. Association between glucose metabolism and sleep-disordered breathing during REM sleep. Am J Respir Crit Care Med 192:9 (2015), 1118–1126.
46. Fendri, S., Rose, D., Myambu, S., et al. Nocturnal hyperglycaemia in type 2 diabetes with sleep apnoea syndrome. Diabetes Res Clin Pract 91:1 (2011), e21–e23.
47. Bialasiewicz, P., Czupryniak, L., Pawlowski, M., et al. Sleep disordered breathing in REM sleep reverses the downward trend in glucose concentration. Sleep Med 12:1 (2011), 76–82.
48. Resnick, H.E., Redline, S., Shahar, E., et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care 26:3 (2003), 702–709.
49. Bottini, P., Redolfi, S., Dottorini, M.L., et al. Autonomic neuropathy increases the risk of obstructive sleep apnea in obese diabetics. Respiration 75:3 (2008), 265–271.
50. Sanders, M.H., Givelber, R., Sleep disordered breathing may not be an independent risk factor for diabetes, but diabetes may contribute to the occurrence of periodic breathing in sleep. Sleep Med 4:4 (2003), 349–350.
51. Bottini, P., Dottorini, M.L., Cristina, C.M., et al. Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy. Eur Respir J 22:4 (2003), 654–660.
52. Lecube, A., Sampol, G., Hernandez, C., et al. Characterization of sleep breathing pattern in patients with type 2 diabetes: Sweet Sleep Study. PLoS One, 10(3), 2015, e0119073.
53. Banghoej, A.M., Nerild, H.H., Kristensen, P.L., et al. Obstructive sleep apnoea is frequent in patients with type 1 diabetes. J Diabetes Complicat 31:1 (2017), 156–161.
54. Borel, A.L., Benhamou, P.Y., Baguet, J.P., et al. High prevalence of obstructive sleep apnoea syndrome in a type 1 diabetic adult population: a pilot study. Diabet Med 27:11 (2010), 1328–1329.
55. Janovsky, C.C., Rolim, L.C., de Sa, J.R., et al. Cardiovascular autonomic neuropathy contributes to sleep apnea in young and lean type 1 diabetes mellitus patients. Front Endocrinol (Lausanne), 5, 2014, 119.
56. Reutrakul, S., Thakkinstian, A., Anothaisintawee, T., et al. Sleep characteristics in type 1 diabetes and associations with glycemic control: systematic review and meta-analysis. Sleep Med 23 (2016), 26–45.
57. Lecube, A., Ciudin, A., Sampol, G., et al. Effect of glycemic control on nocturnal arterial oxygen saturation: a case-control study in type 2 diabetic patients. J Diabetes 7:1 (2015), 133–138.
58. Appleton, S.L., Vakulin, A., McEvoy, R.D., et al. Nocturnal hypoxemia and severe obstructive sleep apnea are associated with incident type 2 diabetes in a population cohort of men. J Clin Sleep Med 11:6 (2015), 609–614.
59. Kendzerska, T., Gershon, A.S., Hawker, G., et al. Obstructive sleep apnea and incident diabetes. A historical cohort study. Am J Respir Crit Care Med 190:2 (2014), 218–225.
60. Marshall, N.S., Wong, K.K., Phillips, C.L., et al. Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton Health Study?. J Clin Sleep Med 5:1 (2009), 15–20.
61. Muraki, I., Tanigawa, T., Yamagishi, K., et al. Nocturnal intermittent hypoxia and metabolic syndrome; the effect of being overweight: the CIRCS study. J Atheroscler Thromb 17:4 (2010), 369–377.
62. Nagayoshi, M., Punjabi, N.M., Selvin, E., et al. Obstructive sleep apnea and incident type 2 diabetes. Sleep Med 25 (2016), 156–161.
63. Botros, N., Concato, J., Mohsenin, V., et al. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med 122:12 (2009), 1122–1127.
64. Boyko, E.J., Seelig, A.D., Jacobson, I.G., et al. Sleep characteristics, mental health, and diabetes risk: a prospective study of U.S. military service members in the Millennium Cohort Study. Diabetes Care 36:10 (2013), 3154–3161.
65. Celen, Y.T., Hedner, J., Carlson, J., et al. Impact of gender on incident diabetes mellitus in obstructive sleep apnea: a 16-year follow-up. J Clin Sleep Med 6:3 (2010), 244–250.
66. Lindberg, E., Theorell-Haglow, J., Svensson, M., et al. Sleep apnea and glucose metabolism: a long-term follow-up in a community-based sample. Chest 142:4 (2012), 935–942.
67. Reichmuth, K.J., Austin, D., Skatrud, J.B., et al. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 172:12 (2005), 1590–1595.
68. Anothaisintawee, T., Reutrakul, S., Van Cauter, E., et al. Sleep disturbances compared to traditional risk factors for diabetes development: Systematic review and meta-analysis. Sleep Med Rev 30 (2015), 11–24.
69. Al-Delaimy, W.K., Manson, J.E., Willett, W.C., et al. Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol 155:5 (2002), 387–393.
70. Strand, L.B., Carnethon, M., Biggs, M.L., et al. Sleep disturbances and glucose metabolism in older adults: the cardiovascular health study. Diabetes Care 38:11 (2015), 2050–2058.
71. Elmasry, A., Janson, C., Lindberg, E., et al. The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population. J Intern Med 248:1 (2000), 13–20.
72. Einhorn, D., Stewart, D.A., Erman, M.K., et al. Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr Pract 13:4 (2007), 355–362.
73. Foster, G.D., Sanders, M.H., Millman, R., et al. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care 32:6 (2009), 1017–1019.
74. Laaban, J.P., Daenen, S., Leger, D., et al. Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients. Diabetes Metab 35:5 (2009), 372–377.
75. Aronsohn, R.S., Whitmore, H., Van Cauter, E., et al. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med 181:5 (2010), 507–513.
76. Lam, D.C., Lui, M.M., Lam, J.C., et al. Prevalence and recognition of obstructive sleep apnea in Chinese patients with type 2 diabetes mellitus. Chest 138:5 (2010), 1101–1107.
77. Tahrani, A.A., Ali, A., Raymond, N.T., et al. Obstructive sleep apnea and diabetic neuropathy: a novel association in patients with type 2 diabetes. Am J Respir Crit Care Med 186:5 (2012), 434–441.
78. Hanis, C.L., Redline, S., Cade, B.E., et al. Beyond type 2 diabetes, obesity and hypertension: an axis including sleep apnea, left ventricular hypertrophy, endothelial dysfunction, and aortic stiffness among Mexican Americans in Starr County. Texas. Cardiovasc Diabetol, 15, 2016, 86.
79. Westlake, K., Plihalova, A., Pretl, M., et al. Screening for obstructive sleep apnea syndrome in patients with type 2 diabetes mellitus: a prospective study on sensitivity of Berlin and STOP-Bang questionnaires. Sleep Med 26 (2016), 71–76.
80. Siwasaranond, N., Nimitphong, H., Saetung, S., et al. Shorter sleep duration is associated with poorer glycemic control in type 2 diabetes patients with untreated sleep-disordered breathing. Sleep Breath 20:2 (2016), 569–574.
81. Zhang, P., Zhang, R., Zhao, F., et al. The prevalence and characteristics of obstructive sleep apnea in hospitalized patients with type 2 diabetes in China. J Sleep Res 25:1 (2016), 39–46.
82. Heffner, J.E., Rozenfeld, Y., Kai, M., et al. Prevalence of diagnosed sleep apnea among patients with type 2 diabetes in primary care. Chest 141:6 (2012), 1414–1421.
83. Mahmood, K., Akhter, N., Eldeirawi, K., et al. Prevalence of type 2 diabetes in patients with obstructive sleep apnea in a multi-ethnic sample. J Clin Sleep Med 5:3 (2009), 215–221.
84. Kent, B.D., Grote, L., Ryan, S., et al. Diabetes mellitus prevalence and control in sleep-disordered breathing: the European Sleep Apnea Cohort (ESADA) study. Chest 146:4 (2014), 982–990.
85. Pillai, A., Warren, G., Gunathilake, W., et al. Effects of sleep apnea severity on glycemic control in patients with type 2 diabetes prior to continuous positive airway pressure treatment. Diabetes Technol Ther 13:9 (2011), 945–949.
86. Priou, P., Le, V.M., Meslier, N., et al. Association between obstructive sleep apnea severity and glucose control in patients with untreated versus treated diabetes. J Sleep Res 24:4 (2015), 425–431.
87. Shaw, J.E., Punjabi, N.M., Wilding, J.P., et al. Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract 81:1 (2008), 2–12.
88. American Diabetes Association. Standards of Medical Care in Diabetes—2017. Diabetes Care 40:Suppl 1 (2017), S1–S142.
89. Coughlin, S.R., Mawdsley, L., Mugarza, J.A., et al. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 29:4 (2007), 720–727.
90. Comondore, V.R., Cheema, R., Fox, J., et al. The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea: a pilot feasibility randomized crossover trial. Lung 187:1 (2009), 17–22.
91. Nguyen, P.K., Katikireddy, C.K., McConnell, M.V., et al. Nasal continuous positive airway pressure improves myocardial perfusion reserve and endothelial-dependent vasodilation in patients with obstructive sleep apnea. J Cardiovasc Magn Reson, 12, 2010, 50.
92. Kohler, M., Stoewhas, A.C., Ayers, L., et al. Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med 184:10 (2011), 1192–1199.
93. Hoyos, C.M., Killick, R., Yee, B.J., et al. Cardiometabolic changes after continuous positive airway pressure for obstructive sleep apnoea: a randomised sham-controlled study. Thorax 67:12 (2012), 1081–1089.
94. Sivam, S., Phillips, C.L., Trenell, M.I., et al. Effects of 8 weeks of continuous positive airway pressure on abdominal adiposity in obstructive sleep apnoea. Eur Respir J 40:4 (2012), 913–918.
95. Kritikou, I., Basta, M., Vgontzas, A.N., et al. Sleep apnoea, sleepiness, inflammation and insulin resistance in middle-aged males and females. Eur Respir J 43:1 (2014), 145–155.
96. Lam, J.C., Lam, B., Yao, T.J., et al. A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur Respir J 35:1 (2010), 138–145.
97. Salord, N., Fortuna, A.M., Monasterio, C., et al. A randomized controlled trial of continuous positive airway pressure on glucose tolerance in obese patients with obstructive sleep apnea. Sleep 39:1 (2016), 35–41.
98. Chirinos, J.A., Gurubhagavatula, I., Teff, K., et al. CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med 370:24 (2014), 2265–2275.
99. Weinstock, T.G., Wang, X., Rueschman, M., et al. A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep 35:5 (2012), 617–625B.
100. Chen, L., Kuang, J., Pei, J.H., et al. Continuous positive airway pressure and diabetes risk in sleep apnea patients: A systemic review and meta-analysis. Eur J Intern Med 39 (2017), 39–50.
101. Shaw, J.E., Punjabi, N.M., Naughton, M.T., et al. The effect of treatment of obstructive sleep apnea on glycemic control in type 2 diabetes. Am J Respir Crit Care Med 194:4 (2016), 486–492.
102. West, S.D., Nicoll, D.J., Wallace, T.M., et al. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 62:11 (2007), 969–974.
103. Mokhlesi, B., Grimaldi, D., Beccuti, G., et al. Effect of one week of 8-hour nightly continuous positive airway pressure treatment of obstructive sleep apnea on glycemic control in type 2 diabetes: a proof-of-concept study. Am J Respir Crit Care Med 194:4 (2016), 516–519.
104. Martinez-Ceron, E., Barquiel, B., Bezos, A.M., et al. Effect of continuous positive airway pressure on glycemic control in patients with obstructive sleep apnea and type 2 diabetes. a randomized clinical trial. Am J Respir Crit Care Med 194:4 (2016), 476–485.
105. Morariu, E.M., Chasens, E.R., Strollo, P.J. Jr., et al. Effect of continuous positive airway pressure (CPAP) on glycemic control and variability in type 2 diabetes. Sleep Breath 21:1 (2017), 145–147.
106. Lam, J.C.M., Lai, A.Y., Tam, T.C.C., et al. CPAP therapy for patients with sleep apnea and type 2 diabetes mellitus improves control of blood pressure. Sleep Breath 21:2 (2017), 377–386.
107. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:9131 (1998), 837–853.
108. Dawson, A., Abel, S.L., Loving, R.T., et al. CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J Clin Sleep Med 4:6 (2008), 538–542.
109. Pallayova, M., Donic, V., Tomori, Z., Beneficial effects of severe sleep apnea therapy on nocturnal glucose control in persons with type 2 diabetes mellitus. Diabetes Res Clin Pract 81:1 (2008), e8–e11.
110. Babu, A.R., Herdegen, J., Fogelfeld, L., et al. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 165:4 (2005), 447–452.
111. Guest, J.F., Panca, M., Sladkevicius, E., et al. Clinical outcomes and cost-effectiveness of continuous positive airway pressure to manage obstructive sleep apnea in patients with type 2 diabetes in the U.K. Diabetes Care 37:5 (2014), 1263–1271.
112. Prasad, B., Carley, D.W., Krishnan, J.A., et al. Effects of positive airway pressure treatment on clinical measures of hypertension and type 2 diabetes. J Clin Sleep Med 8:5 (2012), 481–487.
113. Jullian-Desayes, I., Joyeux-Faure, M., Tamisier, R., et al. Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials. Sleep Med Rev 21 (2015), 23–38.
114. Foster, G.D., Borradaile, K.E., Sanders, M.H., et al. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. Arch Intern Med 169:17 (2009), 1619–1626.
115. Blackman, A., Foster, G.D., Zammit, G., et al. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. Int J Obes (Lond) 40:8 (2016), 1310–1319.
116. Schauer, P.R., Bhatt, D.L., Kirwan, J.P., et al. Bariatric Surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med 376:7 (2017), 641–651.
117. Dixon, J.B., Schachter, L.M., O'Brien, P.E., et al. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA 308:11 (2012), 1142–1149.
118. Greenburg, D.L., Lettieri, C.J., Eliasson, A.H., Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med 122:6 (2009), 535–542.
119. Kaur, A., Mokhlesi, B., The effect of OSA therapy on glucose metabolism: it's all about cpap adherence!. J Clin Sleep Med 13:3 (2017), 365–367.
120. Maahs, D.M., West, N.A., Lawrence, J.M., et al. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 39:3 (2010), 481–497.
121. Mondini, S., Guilleminault, C., Abnormal breathing patterns during sleep in diabetes. Ann Neurol 17:4 (1985), 391–395.
122. Guilleminault, C., Briskin, J.G., Greenfield, M.S., et al. The impact of autonomic nervous system dysfunction on breathing during sleep. Sleep 4:3 (1981), 263–278.